<DOC>
	<DOC>NCT00564564</DOC>
	<brief_summary>The objective of this trial is to compare in an open trial format the efficacy of association of clomipramine and quetiapine with SSRI after SSRI treatment failed to produce complete remission of obsessive compulsive disorder symptoms.</brief_summary>
	<brief_title>Quetiapine Augmentation Versus Clomipramine Augmentation of SSRI for Obsessive-Compulsive Disorder Patients</brief_title>
	<detailed_description>The objective of this trial wis to compare in an randomized open trial format the efficacy of association of clomipramine at maximum dosage of 75mg per day and quetiapine at maximum dosage of 200mg per day with SSRI after SSRI treatment for 12 weeks failed to produce complete remission of OCD symptoms.</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<mesh_term>Clomipramine</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>primary OCD diagnosis according to DSM IV criteria current symptoms were responsible for significant distress previous trial of at least 12 weeks with SSRI (being at least 8 weeks at maximum tolerated dosage) failed to produce full remission of OCD symptoms presence of clinical or neurological diseases that may be worsen by the medications included in treatment protocol current substance dependence or abuse, current psychotic symptoms current suicide risk and current pregnancy or intention to get pregnant before the end of the treatment protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>obsessive compulsive disorder</keyword>
	<keyword>pharmacological treatment</keyword>
	<keyword>quetiapine</keyword>
	<keyword>clomipramine</keyword>
	<keyword>SSRI</keyword>
</DOC>